PPA
FOMX

Parametric Portfolio Associates’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Parametric Portfolio Associates’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-15,627
Closed -$52K – 4061
2019
Q4 		$52K Buy
+15,627
New +$49.7K ﹤0.01% 3920
2017
Q1 		– Sell
-10,182
Closed -$113K – 3833
2016
Q4 		$113K Sell
10,182
-36
-0.4% -$339 ﹤0.01% 3692
2016
Q3 		$95K Sell
10,218
-1,018
-9% -$8.51K ﹤0.01% 3688
2016
Q2 		$71K Buy
11,236
+834
+8% +$5.53K ﹤0.01% 3757
2016
Q1 		$68K Buy
+10,402
New +$67.1K ﹤0.01% 3905

Parametric Portfolio Associates's FOMX Position: Q1 2020 in Review

Parametric Portfolio Associates sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 15,627 shares — an estimated $52K sold.

Parametric Portfolio Associates first reported a position in FOMX in Q1 2016 and held it in 5 quarters. The position peaked at $113K in Q4 2016. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

  • Parametric Portfolio Associates reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
  • Parametric Portfolio Associates sold 15,627 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $52K.
  • Parametric Portfolio Associates first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2016 and held it in 5 quarters.
  • Parametric Portfolio Associates's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $113K in Q4 2016.
  • 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Parametric Portfolio Associates's 13F filing for Q1 2020, filed 13 May 2020.